Science
Business Development Manager
Last updated
Business Development Managers in science and biotech companies support the identification, evaluation, and execution of external partnerships, licensing opportunities, and commercial agreements. Working under senior BD leadership, they build deal pipelines, run due diligence work streams, support contract negotiations, and manage active partnership relationships — gaining the transaction experience and industry network needed to advance to director-level roles.
Role at a glance
- Typical education
- Ph.D./M.D. or M.S. in life sciences + MBA
- Typical experience
- 4-8 years
- Key certifications
- None typically required
- Top employer types
- Pharmaceutical companies, biotech firms, life sciences investment banking, management consulting
- Growth outlook
- Stable demand driven by structural need for external innovation and expanding global transaction volumes.
- AI impact (through 2030)
- Augmentation — AI-driven drug discovery and digital health assets are creating new deal categories, increasing the need for BD professionals who can value technology-licensing structures.
Duties and responsibilities
- Source and screen external partnership and licensing opportunities through company databases, conference attendance, and professional networks
- Prepare opportunity assessments summarizing scientific rationale, competitive landscape, and preliminary deal economics
- Coordinate multi-functional due diligence processes: schedule and manage scientific, regulatory, legal, and financial workstreams
- Build financial models for opportunity valuation: rNPV analysis, comparable transaction benchmarking, sensitivity analysis
- Draft and review term sheets, CDAs, MTAs, and letter agreements under senior direction
- Maintain CRM systems and BD pipeline tracking tools with current opportunity status and follow-up actions
- Represent the company at industry conferences and build relationships with external biotech, academic, and investor contacts
- Support preparation of presentations for internal scientific committees, executive reviews, and board meetings
- Manage governance activities for active partnerships: prepare materials for joint steering committee meetings and track milestone progress
- Conduct competitive intelligence research on therapeutic area trends, competitor pipeline activities, and deal terms
Overview
Business Development Managers are the analytical and logistical engine behind pharmaceutical deal-making. While the BD Director develops strategy and leads negotiations, the BD Manager does the substantive work that makes deals possible: screening the opportunity landscape, building the financial models, coordinating the due diligence teams, writing the opportunity assessments, and maintaining the relationships and pipeline systems that keep BD operations running.
Opportunity screening is a core BD manager activity. The external biotech landscape generates hundreds of potential licensing targets, collaboration proposals, and technology showcases every year. The manager's job is to quickly assess which are worth further attention — reading data packages, evaluating competitive positioning, checking patent landscapes, and flagging scientifically or commercially uncompetitive opportunities before they consume expensive senior scientist time.
Financial modeling for pharmaceutical deals requires specific skills. rNPV models require clinical stage transition probabilities (publicly available from sources like BIO, IQVIA, and Citeline), market size estimates for the indication, competitive landscape adjustments, and deal cost assumptions. These models are inherently uncertain — the inputs are uncertain, the drug may never make it to market — but they create a framework for comparing opportunities and anchoring negotiation positions. BD managers who build models their principals trust and understand are more effective than those who build black-box spreadsheets.
Conference work is a significant time investment. A BD manager at an active company will attend 8–15 industry events per year, preparing targeted meeting lists in advance, conducting back-to-back 30-minute meetings with external companies, and following up on every meaningful conversation within 48 hours. The relationship infrastructure built through this activity pays off over years, not months.
Qualifications
Education:
- Ph.D. or M.D. with strong interest in commercial side (most competitive for pharma and innovative biotech)
- M.S. in life sciences plus MBA from a recognized program
- B.S. in life sciences plus MBA acceptable for more commercially-oriented BD roles
Experience:
- 4–8 years of total experience in pharmaceutical/biotech business development, corporate development, life sciences investment banking, or management consulting (life sciences)
- Direct BD role experience preferred; investment banking background with pharma deal experience is a recognized alternate path
- Track record of supporting (not just participating in) at least 2–3 closed transactions
Analytical skills:
- Financial modeling: NPV, rNPV, DCF, comparable transaction analysis in pharmaceutical contexts
- Deal structure literacy: milestone waterfall design, royalty tier structures, sublicensing fee splits
- Scientific evaluation: ability to read IND-stage data packages and assess quality, completeness, and major red flags
- Competitive intelligence: therapeutic area trend analysis, deal trend synthesis, competitor pipeline monitoring
Tools and data sources:
- Pharma industry databases: Citeline (previously Pharma Intelligence), Evaluate Pharma, GlobalData
- CRM and pipeline management: Salesforce, Seismic, or company-specific tools
- Deal databases: BioCentury, Thomson Reuters (Cortellis), SEC filings for public deal terms
What differentiates strong candidates:
- Network that has already produced at least one BD conversation or lead, not just conference attendance
- Clear scientific credibility — can read a clinical data package and identify the key questions it leaves unanswered
- Ability to communicate deal rationale clearly in writing: opportunity assessments, executive summaries, board materials
Career outlook
Business development roles in life sciences remain among the most competitive and well-compensated paths available to science professionals who want to combine commercial acumen with scientific expertise. The fundamental driver — large pharmaceutical companies need external innovation to fill pipelines — is structural and isn't changing.
The volume of cross-border and global pharmaceutical transactions has grown, expanding the scope of BD work beyond domestic deal-making. European biotech, Asian pharmaceutical companies seeking U.S. market access, and the increasing activity of Chinese and Korean firms in Western pharmaceutical markets have created BD demand for professionals comfortable with international deal structures and cross-cultural negotiation.
Digital health and data assets have become a major new deal category. Pharmaceutical companies acquiring AI-based drug discovery platforms, real-world evidence data assets, and digital therapeutics are executing transactions that look more like technology deals than traditional pharmaceutical licensing. BD professionals who understand both the scientific and technology-licensing sides of these deals are increasingly valuable.
For BD managers who want to accelerate career progress, getting on a large deal — even in a support role — is more valuable than executing multiple small deals independently. The learning from one full transaction cycle (from first contact through term sheet negotiation through final agreement and governance kickoff) is difficult to replicate any other way.
The director track requires demonstrating deal ownership — not just supporting others' deals — and relationship-based deal sourcing. BD managers who build genuine industry relationships that generate deal conversations, rather than just attending conferences, distinguish themselves from peers and advance faster. The career ceiling at Director, VP, and SVP levels offers one of the better compensation trajectories available to life science professionals without moving into investment banking or venture capital.
Sample cover letter
Dear Hiring Manager,
I'm applying for the Business Development Manager position at [Company]. I have five years of experience in pharmaceutical business development at [Company], where I've supported eight transactions from initial screening through close, including two in-licensing deals and one platform collaboration with an academic medical center.
My strongest contributions have been on the evaluation and modeling side. I built the financial model for our most recent in-licensing deal — a Phase II asset in [therapeutic area] — and the assumptions I put into the probability-adjusted NPV model were central to the internal discussion about pricing. When the negotiation came to a head on milestones, I ran the sensitivity analysis that showed we had about 15% of flexibility in the commercial milestone before the deal's rNPV crossed our internal hurdle rate. That analysis informed the BD director's position in the final negotiation session.
I've also been building conference relationships seriously for three years. I initiated contact with two companies whose assets we later licensed through initial conversations at BIO that I scheduled with targeted preparation rather than general networking. Those conversations happened because I'd read their data package before the conference and had specific scientific questions that opened real dialogue.
The opportunity at [Company] interests me because of [specific program focus or therapeutic area] and because your pipeline stage — primarily early-phase in-licensing — matches where I've had the most substantive involvement. I'd welcome a conversation about your BD strategy and team structure.
Thank you for your time.
[Your Name]
Frequently asked questions
- How is a Business Development Manager different from a Business Development Director?
- Managers typically operate under closer supervision and take direction on strategic priorities, while directors lead independently on both strategy and execution. Managers build the analytical and relational foundations — sourcing, screening, modeling, diligence coordination — while directors own deals from strategy through close. The promotion to director usually requires demonstrating deal ownership (not just support), relationship-based deal sourcing, and leadership in negotiation.
- What analytical skills are most important for BD Managers in pharma?
- Financial modeling is essential: building NPV and rNPV models, structuring comparable transaction analyses, and being able to defend assumptions. Competitive intelligence synthesis — distilling what dozens of competitor pipeline moves and deal announcements mean for a company's strategy — is equally important. The ability to write a clear, concise opportunity assessment that gives decision-makers what they need without burying them is a skill that develops over time and is genuinely valued.
- Do Business Development Managers in biotech need a scientific degree?
- Scientific training — typically at least a master's, and often a Ph.D. — is strongly preferred at most pharmaceutical and innovative biotech companies because BD managers must evaluate data packages, engage credibly with scientists during due diligence, and present to scientific committees. MBA-only candidates are competitive for more commercially-oriented BD roles at tools, diagnostics, or CDMO companies, where the evaluation is more commercial than scientific.
- What is a materials transfer agreement and why do BD Managers deal with them?
- A materials transfer agreement (MTA) is a contract governing the transfer of biological, chemical, or other research materials between organizations. They're often the first formal document in a potential partnership — a company shares a compound or tool with an academic lab for evaluation, or receives a material from a partner. BD managers often handle MTA reviews and routing because they're frequent, important for relationship management, and a precursor to larger deals.
- What conferences should a Biotech BD Manager attend?
- The JP Morgan Healthcare Conference in January is the premier annual deal-making event for the sector. BIO International Convention is the largest life sciences industry event. BioEurope and BioEurope Spring are important for European partnerships. Disease-area specific conferences (ASCO, ASH, ESMO for oncology; WCBP for biologics) are important for scientific network building. The value of conferences is almost entirely in the side meetings, not the sessions — scheduling 1:1 meetings in advance is essential.
More in Science
See all Science jobs →- Business Development Director$140K–$225K
Business Development Directors in the science and biopharmaceutical sector identify, evaluate, and execute external growth opportunities — licensing deals, acquisitions, research collaborations, and strategic partnerships. They translate scientific pipeline gaps into commercial opportunities, negotiate deal structures worth tens to hundreds of millions of dollars, and build the relationships that make complex multi-party agreements possible.
- Chemical Engineer$75K–$130K
Chemical Engineers apply the principles of chemistry, physics, and mathematics to design, optimize, and operate processes that convert raw materials into useful products — from petroleum refining to pharmaceutical manufacturing to polymer production. They work at the intersection of scientific knowledge and industrial-scale operations, ensuring that processes are efficient, safe, and economically viable.
- Biotech Research Associate$50K–$80K
Biotech Research Associates conduct laboratory experiments supporting drug discovery and development projects, executing protocols in cell biology, molecular biology, or biochemistry under the direction of senior scientists. They bridge the gap between scientific concept and experimental data, making scientific ideas testable and generating the measurements that move programs forward.
- Clinical Data Analyst$65K–$105K
Clinical Data Analysts ensure the accuracy, completeness, and regulatory compliance of clinical trial data — cleaning records, querying investigators for inconsistencies, programming validation checks, and preparing datasets for statistical analysis and regulatory submission. Their work is the quality control step between raw patient data collected at clinical sites and the clean, analyzable datasets that biostatisticians use to evaluate drug safety and efficacy.
- Director of Quality Assurance$140K–$205K
Directors of Quality Assurance build and lead the quality management systems, audit programs, and regulatory compliance infrastructure that protect organizations from FDA and EMA enforcement actions. They oversee internal and vendor audits, manage inspection preparedness, write and enforce quality SOPs, and serve as the primary quality authority in interactions with health authorities.
- Quality Assurance Auditor$68K–$108K
Quality Assurance Auditors assess whether pharmaceutical, biotech, and medical device manufacturing and laboratory operations conform to applicable GMP regulations, ISO standards, and internal quality system requirements. They conduct internal, supplier, and regulatory inspection readiness audits, document findings, track corrective actions, and help organizations maintain the compliance posture that protects product quality and patient safety.